Skip to content

Clinical trials

Phase 1 Mood Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mood Disorders Phase: Phase 1 Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20036
20046
20052
20065
20073
20092
20101
20112
20121
20132
20151
20172
20183
20192
20212
20221
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed43
Recruiting2
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.21
University Hospital, Basel, Switzerland6
Luye Pharma Group Ltd.5
BrainCells Inc.2
Behman Hospital1
Brigham and Women's Hospital1
Integrative Psychiatry Institute1
Laureate Institute for Brain Research, Inc.1
Mary Fristad1
Minneapolis Veterans Affairs Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mood Disorders47
Schizophrenia23
Major Depressive Disorder10
Mental Disorders9
Psychotic Disorders7
Depressive Disorder6
Substance-Related Disorders6
Amphetamine-Related Disorders5
Depressive Disorder, Treatment-Resistant5
Anxiety Disorders3

Trials

Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.